BioAge Labs target price cut to $40 from $73
BIOA•Piper Sandler cut its target price for BioAge Labs to $40 from $73.
Related News
Brookfield Asset Management Ltd: Piper Sandler raises target price to $52 from $49
BAM•
Asian stocks steady as AI, Mideast jitters recede; dollar firm on Fed bets
SPY•
Alight appoints Vikram Kalra as India country leader
ALIT•
Almonty Industries' Sangdong finished grade approaches 50%, up from 40%
ALM•
Why Taiwan’s AI moat trumps South Korea's memory bet: Manishi Raychaudhuri
SMH•